NCBiotech News

Federal health officials have tapped RTI International to join a collaboration tracking COVID-19’s ability to cause severe illness and the effectiveness of proposed treatments.

A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell therapy startups with plans to build an $83 million biomanufacturing facility in Durham that could employ more than 200 people over five years.

Natural food coloring innovator GNT USA, Inc. plans to invest $30 million to build its first U.S. food processing facility which will ultimately employ about 40 people in Gaston County, about 25 miles west of Charlotte.

The Dole Food Company has entered a five-year strategic partnership with the young RTP-based ag tech company Elo Life Systems to keep bananas alive and available, because Elo's gene editing technology is uniquely qualified to develop Fusarium-resistant banana varieties.

North Carolina’s economic development efforts are recognized in Business Facilities magazine’s 2020 Metro Rankings Report, with the City of Raleigh number one on its list of GDP leaders in mid-size metro markets.

The North Carolina Biotechnology Center awarded 34 grants and loans totaling nearly $2 million to universities, biosciences companies and other entities in the fourth quarter of its last fiscal year.

Grifols, a global biotherapeutics company with major operations in North Carolina, has delivered the first batches of a therapeutic product manufactured in Clayton that could help prevent and treat COVID-19 infection.

North Carolina’s strength in the life sciences and its strong business climate have landed it, again, among the nation’s best on Business Facilities Magazine's 16th Annual Rankings Report for 2020.

A British startup which opened U.S. headquarters in Raleigh earlier this year, Verona Pharma,​ has landed a $200 million “oversubscribed” private placement of stock.

Greensboro diagnostics and drug screening company Carolina Liquid Chemistries (CLC) is now selling COVID-19 test kits.

Raleigh pharmaceutical upstart 9 Meters Biopharma has secured patent protection for its potential gastrointestinal drug for additional use in treating lung disease. 

RTP oncology company G1 Therapeutics has out-licensed a potential drug for treating certain breast and lung cancers to a Massachusetts startup in a deal that could be worth more than $300 million.

RTP-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic researchers as part of its efforts to accelerate research on how COVID-19 is impacting the healthcare industry and related treatment.

The NCBiotech-supported Summer Undergraduate Research Program at Western Carolina University has adapted well to the world of digital communication.

Winston-Salem's EncepHeal Therapeutics has landed a federal grant to support development of its novel medications for cocaine addiction.